GlassScriptPhysician profile
Christopher Caruso
NPI 1184039554
$4,829.25
in general payments reported to CMS, 2019-2025
6 companies · $44.02 in 2025
The $44.02 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.92 · 2022: $50.22 · 2023: $162 · 2024: $4,521 · 2025: $44.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,424 · Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,424.27 |
| Food and Beverage | $302.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $4,524.90 | 2023-2024 | Other - Miscellaneous |
| Abbott Laboratories | $139.53 | 2023-2025 | Proclaim, Swift-Lock, Octrode |
| Providence Medical Technology, INC. | $75.72 | 2022-2023 | |
| Clariance, INC. | $51.92 | 2021 | |
| Si-Bone, INC. | $20.37 | 2022 | |
| Bioventus LLC | $16.81 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Caruso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.